Zobrazeno 1 - 10
of 3 193
pro vyhledávání: '"Treatment resistant schizophrenia"'
Publikováno v:
Indian Journal of Health Sciences and Biomedical Research KLEU, Vol 17, Iss 3, Pp 250-254 (2024)
AIM: The aim of the study was to study the efficacy of modified electroconvulsive therapy (MECT) as an augmentation agent in schizophrenia, with particular emphasis in treatment-resistant schizophrenia. MATERIAL AND METHODS: A prospective open-label,
Externí odkaz:
https://doaj.org/article/45288af75b1544a3b65ce789922ee03c
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundAlthough the number of studies on treatment-resistant schizophrenia (TRS) has been increasing, the global research hotspots and future research trends have not yet been established.ObjectiveThis study identify the hotspots of TRS research a
Externí odkaz:
https://doaj.org/article/4cc4b4749188485e979602004b5c9467
Autor:
Dan Siskind, Claudia Bull, Shuichi Suetani, Nicola Warren, Anastasia Suraev, Iain McGregor, Steve Kisely, Veronica De Monte, Mike Trott, Manju Shine, Vikas Moudgil, Gail Robinson, Stephen Parker, Ravikumar Krishnaiah, Terry Stedman, Allan Drummond, Sarah Medland, Ravi Iyer, Andrea Baker
Publikováno v:
BJPsych Open, Vol 10 (2024)
Background Although clozapine is the most effective antipsychotic for people with treatment-resistant schizophrenia (TRS), only 40% of people with TRS respond, and there is limited evidence for augmentation agents. Cannabidiol (CBD) reduces positive
Externí odkaz:
https://doaj.org/article/64ebe2dac8b946738e5425288d414a3a
Autor:
Jingqi He, Jinguang Li, Yisen Wei, Zhangyin He, Junyu Liu, Ning Yuan, Risheng Zhou, Xingtao He, Honghong Ren, Lin Gu, Yanhui Liao, Xiaogang Chen, Jinsong Tang
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Glutamatergic function abnormalities have been implicated in the etiology of treatment-resistant schizophrenia (TRS), and the efficacy of clozapine may be attributed to its impact on the glutamate system. Recently, evidence has em
Externí odkaz:
https://doaj.org/article/49563322fe4a4051a83dc7786efde292
Publikováno v:
BMC Psychiatry, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background Inflammation has an important role in the pathogenesis of schizophrenia. The aim of this study was to investigate the levels of tumor necrosis factor (TNF) and matrix metalloproteinase-2 (MMP-2) in male patients with treatment-res
Externí odkaz:
https://doaj.org/article/9bfbf3650b3b400382cad04e3af22825
Autor:
Jonatan M. Panula, Athanasios Gotsopoulos, Jussi Alho, Jaana Suvisaari, Maija Lindgren, Tuula Kieseppä, Tuukka T. Raij
Publikováno v:
Biomarkers in Neuropsychiatry, Vol 11, Iss , Pp 100102- (2024)
As many as one third of the patients diagnosed with schizophrenia do not respond to first-line antipsychotic medication. This group may benefit from the atypical antipsychotic medication clozapine, but initiation of treatment is often delayed, which
Externí odkaz:
https://doaj.org/article/f2b700f608e3475cb71986b77592d538
Publikováno v:
Frontiers in Psychiatry, Vol 15 (2024)
IntroductionPredictors of functioning are well-studied in schizophrenia, but much less so in treatment-resistant schizophrenia (TRS). In this study, we aim to investigate contributions of schizophrenia symptom domains and neurocognition to predict fu
Externí odkaz:
https://doaj.org/article/c20d2fe6f4aa4d9989224b556b14c674
Autor:
Asad Ullah Jan, Sajid Rahim
Publikováno v:
Pakistan Armed Forces Medical Journal, Vol 74, Iss 3 (2024)
Objective: To determine the delay in Clozapine initiation in patients with treatment-resistance schizophrenia who presented to the Tertiary psychiatric facilities. Study Design: Cross-sectional study. Place and Duration of Study: Department of Ps
Externí odkaz:
https://doaj.org/article/d1e0d7f611b84b67aba1ab73c731c06e
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jingqi He, Yisen Wei, Jinguang Li, Ying Tang, Junyu Liu, Zhangyin He, Risheng Zhou, Xingtao He, Honghong Ren, Yanhui Liao, Lin Gu, Ning Yuan, Xiaogang Chen, Jinsong Tang
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Low-grade inflammation and altered inflammatory markers have been observed in treatment-resistant schizophrenia (TRS). Interleukin-6 (IL-6) is one of the pro-inflammatory cytokines linked with TRS and receives increasing attention
Externí odkaz:
https://doaj.org/article/7491a49feb2540f98337c5127025152b